<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cardiovasc Magn Reson</journal-id><journal-id journal-id-type="iso-abbrev">J Cardiovasc Magn Reson</journal-id><journal-title-group><journal-title>Journal of Cardiovascular Magnetic Resonance</journal-title></journal-title-group><issn pub-type="ppub">1097-6647</issn><issn pub-type="epub">1532-429X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26024662</article-id><article-id pub-id-type="pmc">4449586</article-id><article-id pub-id-type="publisher-id">139</article-id><article-id pub-id-type="doi">10.1186/s12968-015-0139-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Rodr&#x000ed;guez-Palomares</surname><given-names>Jos&#x000e9; F.</given-names></name><address><phone>+3493 4893000</phone><fax>+3493 2746063</fax><email>jfrodriguezpalomares@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Ortiz-P&#x000e9;rez</surname><given-names>Jos&#x000e9; T.</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Daniel C.</given-names></name><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Bucciarelli-Ducci</surname><given-names>Chiara</given-names></name><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Tejedor</surname><given-names>Paula</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Bonow</surname><given-names>Robert O</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Edwin</given-names></name><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><aff id="Aff1"><label/>Department of Cardiology, Institut de Recerca (VHIR), Hospital Universitari Vall d&#x000b4;Hebron, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </aff><aff id="Aff2"><label/>Department of Medicine, Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL USA </aff><aff id="Aff3"><label/>Departments of Medicine and Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL USA </aff><aff id="Aff4"><label/>Department of Cardiology, Hospital Universitari Vall d&#x02019;Hebron, Paseo Vall d&#x02019;Hebron 119-129, Barcelona, 08035 Spain </aff><aff id="Aff5"><label/>Bristol Heart Institute, NIHR Bristol Cardiovascular Biomedical Research Unit, University of Bristol, Bristol, UK </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>43</elocation-id><history><date date-type="received"><day>30</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>1</day><month>5</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Rodr&#x000ed;guez-Palomares et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>In acute myocardial infarction (MI), late Gadolinium enhancement (LGE) has been proposed to include the infarcted myocardium and area at risk. However, little information is available on the optimal timing after contrast injection to differentiate these 2 areas. Our aim was to determine in acute and chronic MI whether imaging time after contrast injection influences the LGE size that better predicts infarct size and functional recovery.</p></sec><sec><title>Methods</title><p>Subjects were evaluated by cardiovascular magnetic resonance (CMR) the first week (n&#x02009;=&#x02009;60) and 3&#x000a0;months (n&#x02009;=&#x02009;47) after a percutaneously revascularized STEMI. Inversion-recovery single-shot (ss-IR) imaging was acquired at multiple time points following contrast administration and compared to segmented inversion-recovery (seg-IR) sequences. Inversion time was properly adjusted and images were blinded, randomized and measured for LGE volumes.</p></sec><sec><title>Results</title><p>In acute MI, LGE volume decreased over several minutes (p&#x02009;=&#x02009;0.005) with the greatest volume occurring at 3&#x000a0;minutes and the smallest at 25&#x000a0;minutes post-contrast injection; however, LGE volume remained constant over time in chronic MI (p&#x02009;=&#x02009;0.886). Depending on the imaging time, in acute phase, a change in the transmurality index was also observed. A transmural infarction (&#x0003e;75%) at 25&#x000a0;minutes better predicted the absence of improvement in the wall motion score index (WMSI), a higher increase in left ventricular volumes and a lower ejection fraction compared to 10&#x000a0;minutes.</p></sec><sec><title>Conclusions</title><p>A change was observed in LGE volume in the minutes following contrast administration in acute but not in chronic MI. Infarct transmurality 25&#x000a0;minutes post-contrast injection better predicted infarct size and functional recovery at follow-up.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cardiovascular magnetic resonance</kwd><kwd>Infarct size</kwd><kwd>Microvascular obstruction</kwd><kwd>Gadolinium</kwd><kwd>Dynamic change</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Cardiovascular magnetic resonance (CMR) utilizing the late Gadolinium enhancement (LGE) technique is a highly accurate method for characterizing reversible and irreversible myocardial injury to obtain information on myocardial viability in both acute and chronic myocardial infarction [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>]. Studies in a canine model with 2-day-old reperfused infarcts showed that regions of LGE directly corresponded to regions of infarcted tissue assessed by triphenyltetrazolium chloride staining (TTC) [<xref ref-type="bibr" rid="CR3">3</xref>]. Gadolinium-based contrast agents using doses of&#x02009;&#x02265;&#x02009;0.2&#x000a0;mmol/kg body weight have subsequently been shown to be effective in the detection and assessment of both acute and chronic myocardial infarction (MI) in large cohorts and multicenter clinical studies [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>However, early studies in animal models conducted at different minutes after the administration of contrast in reperfused acute MI showed that the area of LGE could potentially overestimate the true extent of infarction [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Moreover, studies in humans performed after an acute MI showed that some transmural regions of LGE recover function over time [<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref>]. These findings suggested that Gadolinium enhancement can potentially occur in both reversibly- and irreversibly-injured myocardium. A recent study has confirmed that early enhancement 2&#x000a0;minutes after contrast injection depicted both ischemically-injured but salvaged myocardium and infarcted myocardium, whereas LGE 10&#x02013;15 minutes after contrast injection revealed only the infarcted myocardium [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>Rather than conclude that Gadolinium overestimates acute infarct size, it is more challenging to understand the kinetics of Gadolinium contrast enhancement and its wash-out to determine why Gadolinium can show both the penumbra of the area at risk and the core of the LGE that represents the infarct [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>The aims of this study were to serially investigate differences in LGE and MVO sizes over time after contrast injection in acute and chronic infarcts and also to determine the timing post-contrast that better predicts myocardial functional recovery, left ventricular volumes and ejection fraction.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Patients</title><p>Between January 2006 and July 2008, 72 patients admitted to the coronary care unit following an ST-segment elevation acute myocardial infarction (STEMI) successfully reperfused through percutaneous coronary intervention (PCI) were prospectively enrolled. Patients were included if they fulfilled the criteria of documented acute STEMI with [<xref ref-type="bibr" rid="CR1">1</xref>] chest pain for more than 30&#x000a0;minutes, [<xref ref-type="bibr" rid="CR2">2</xref>] at least 1.0&#x000a0;mm ST-segment elevation in two contiguous leads, and [<xref ref-type="bibr" rid="CR3">3</xref>] elevated creatinine phosphokinase MB (CPKMB) isoenzyme or troponin I levels more than two times higher than normal. Patients with a known history of previous acute MI, PCI or coronary artery bypass surgery, frequent and recurrent ventricular arrhythmias, unstable hemodynamics (NYHA class IV), or contraindications to CMR (such as pacemakers, defibrillator) were excluded. A total of 60 patients were finally included in the study. The protocol was approved by the Ethics Committee of our institution, and all patients signed their informed consent.</p></sec><sec id="Sec4"><title>Cardiovascular Magnetic Resonance</title><p>All CMR studies were performed with a 1.5&#x000a0;T clinical scanner (Sonata or Avanto scanner Siemens, Erlangen, Germany) using a phased-array cardiac receiver coil. Retrospectively electrocardiogram-gated breath-hold short-axis cine views were performed to quantify volumes and ejection fraction (SSFP sequences; slice thickness: 6&#x000a0;mm; space between slices 67%; matrix: 256x256: field of view: 300-370&#x000a0;mm; temporal resolution &#x0003c;50&#x000a0;ms). Additional 2-chamber, 3-chamber and 4-chamber views were also obtained. LGE images were acquired at identical slice positions to the cine images after the administration of 0.2&#x000a0;mmol/kg of body weight Gadolinium-DTPA (Gd-DTPA) (Berlex, Montville, NJ, USA). A single-shot inversion recovery (ss-IR) steady-state free precession sequence [<xref ref-type="bibr" rid="CR12">12</xref>] was acquired at repeated time points, 1, 3, 5, 7, 10, 15, 20 and 25&#x000a0;minutes following contrast administration (Matrix 192 &#x000d7; 144, voxel size 2.4 &#x000d7; 1.8 &#x000d7; 6&#x000a0;mm, TE 1.08&#x000a0;ms, TR 700&#x000a0;ms, flip angle 50&#x000b0;; and the bandwidth 1180&#x000a0;Hz/pixel). The cutoff value of 25&#x000a0;minutes was established based on previous experimental studies by Oshinski et al. [<xref ref-type="bibr" rid="CR5">5</xref>]. Inversion time (IT) was appropriately set at any time point to null normal myocardium[<xref ref-type="bibr" rid="CR13">13</xref>]. In addition, a segmented inversion-recovery (seg-IR) gradient-echo sequence was acquired starting at 10&#x000a0;min after contrast administration (Matrix 256 &#x000d7; 197, voxel size 2.0 &#x000d7; 1.6 &#x000d7; 6&#x000a0;mm, TE 4.91&#x000a0;ms, TR 700&#x000a0;ms, flip angle 30&#x000b0;; and the bandwidth 140&#x000a0;Hz/pixel) [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref>].</p><sec id="Sec5"><title>Image analysis</title><p>Quantitative analyses of left ventricular (LV) mass, end-diastolic volume (EDV), end-systolic volume (ESV) and ejection fraction (EF) were performed by manually tracing the epicardial and endocardial borders as previously described [<xref ref-type="bibr" rid="CR15">15</xref>]. Volume indices were calculated by dividing the EDV or ESV by body surface area. Contractility was analyzed and the wall motion score index estimated (WMSI) [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>For objective quantification of LGE and MVO, a reference region of interest (ROI) was placed in remote myocardium. The signal intensity threshold indicating LGE was imposed 2 standard deviations (SD) above the mean intensity of the reference ROI on each of the contrast-enhanced CMR tomograms and summed, as previously described [<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref>]. Microvascular obstruction (MVO) was defined as the low intensity core within an area of LGE. <italic>Early MVO</italic> were considered if they were present 1&#x000a0;minute after contrast administration [<xref ref-type="bibr" rid="CR16">16</xref>] and <italic>late MVO</italic> when seen 10&#x000a0;min later [<xref ref-type="bibr" rid="CR17">17</xref>], on single-shot images. Areas of MVO were included in the total LGE area [<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref>]. The summed area was multiplied by the specific gravity of myocardium to obtain the LGE volume. Relative LGE volume was the percentage of total LV mass (% of LV mass) that presented LGE. To assess the kinetics of Gd-DTPA, all images obtained by the ss-IR (<italic>acute and chronic CMRs</italic>) were blinded, randomized and measured for LGE volumes; 990 stacks of images were analyzed. Dynamic changes in LGE were evaluated with the use of different parameters: LGE volume, relative LGE volume, LGE transmurality and LGE lateral extension.</p><p>LGE transmurality was expressed as the mean percentage of transmurality of the LGE in all affected slices at each time point. Transmurality in each slice was calculated by dividing the LGE mass by the total mass of the affected myocardium in each segment [<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref>].</p><p>LGE lateral extension was determined by calculation of the infarct endocardial surface area (Infarct-ESA), as previously described [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p>Further, single-shot stacks of images in the <italic>acute and chronic</italic> CMRs were analyzed using different standard deviations (2, 3, 4 and 5) over remote signal intensity to establish the effect of different thresholds on LGE volume.</p><p>Signal intensity was obtained in the hyperenhanced area, the remote myocardium and background noise for calculation of the signal-to-noise and contrast-to-noise ratios [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p>In a subset of 56 stacks of single-shot images including a mix of acute and chronic CMRs, interobserver and intraobserver reproducibility was performed.</p><p>Finally, the LGE volume obtained with seg-IR sequences was measured and compared with the volume obtained by the ss-IR at the same slice position and same time point in order to compare both sequences.</p></sec></sec><sec id="Sec6"><title>Statistical analysis</title><p>Continuous demographic variables were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation. The Kolmogorov-Smirnov test was used to evaluate the normality distribution of variables. Inter-group differences for continuous parameters were assessed by Student's <italic>t</italic>-test if they presented a normal distribution or ANOVA with Bonferroni correction for multiple comparisons, and Mann&#x02013;Whitney <italic>U</italic> test if they did not present a normal distribution. For categorical variables, general characteristics of the sample were assessed by percentages (chi-square test). Interobserver and intraobserver variabilities were calculated using the intraclass correlation coefficient. Agreement between ss-IR and seg-IR sequences was examined using the intraclass correlation coefficient and Bland&#x02013;Altman analysis.</p><p>A two-tailed P value&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. SPSS 19.0 software version (IBM SPSS Statistics, Chicago, Illinois, USA) was used for the analysis.</p></sec></sec><sec id="Sec7" sec-type="results"><title>Results</title><sec id="Sec8"><title>Baseline characteristics</title><p>The clinical and angiographic characteristics of patients are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. All subjects had successful reperfusion with PCI within 24&#x000a0;hours of admission. CMR studies were performed within 1&#x000a0;week (<italic>Acute CMR</italic>, mean: 2.6&#x02009;&#x000b1;&#x02009;1.5&#x000a0;days; range: 1&#x02013;6) and approximately 4&#x000a0;months (<italic>Chronic CMR</italic>, mean: 122.1&#x02009;&#x000b1;&#x02009;29.7&#x000a0;days; range: 78&#x02013;195 days) after admission.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical characteristics for all subjects (n&#x02009;=&#x02009;60)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>
<bold>Risk factors</bold>
</td><td/></tr><tr><td>Age (years)<sup>1</sup>
</td><td char="&#x000b1;" align="char">57&#x02009;&#x000b1;&#x02009;10</td></tr><tr><td>Male</td><td>49 (81.67%)</td></tr><tr><td>Diabetes mellitus</td><td>3 (5%)</td></tr><tr><td>Hypertension</td><td>25 (41.67%)</td></tr><tr><td>Hypercholesterolemia</td><td>30 (50%)</td></tr><tr><td>Tobacco use</td><td>30 (50%)</td></tr><tr><td>
<bold>Clinical Data</bold>
</td><td/></tr><tr><td>Symptom-to-balloon (<italic>median</italic>) (min)</td><td char="." align="char">197</td></tr><tr><td>Door-to-balloon (<italic>median</italic>) (min)</td><td char="." align="char">85.5</td></tr><tr><td>Maximum total CK MB (IU/L)<sup>1</sup>
</td><td char="&#x000b1;" align="char">243.65&#x02009;&#x000b1;&#x02009;239.64</td></tr><tr><td>Maximum total Troponine T (ng/L)<sup>1</sup>
</td><td char="&#x000b1;" align="char">53.43&#x02009;&#x000b1;&#x02009;80.65</td></tr><tr><td>
<bold>Angiographic findings</bold>
</td><td/></tr><tr><td>Left anterior descending IRA</td><td>33 (55%)</td></tr><tr><td>Left circumflex IRA</td><td>6 (10%)</td></tr><tr><td>Right coronary IRA</td><td>21 (35%)</td></tr><tr><td>
<italic><underline>TIMI pre-procedure</underline></italic>
</td><td/></tr><tr><td>TIMI 0</td><td>43 (71.67%)</td></tr><tr><td>TIMI 1</td><td>10 (16.67%)</td></tr><tr><td>TIMI 2</td><td>5 (8.33%)</td></tr><tr><td>TIMI 3</td><td>2 (3.33%)</td></tr><tr><td>
<italic><underline>TIMI post-procedure</underline></italic>
</td><td/></tr><tr><td>TIMI 2</td><td>7 (11.67%)</td></tr><tr><td>TIMI 3</td><td>53 (88.33%)</td></tr><tr><td>
<italic><underline>Rentrop Scale</underline></italic>
</td><td/></tr><tr><td>0</td><td>22 (36.67%)</td></tr><tr><td>1</td><td>16 (26.67%)</td></tr><tr><td>2</td><td>15 (25%)</td></tr><tr><td>3</td><td>7 (11.67%)</td></tr><tr><td>
<bold>MRI Data</bold>
</td><td/></tr><tr><td>
<italic><underline>Acute MRI</underline></italic>
</td><td/></tr><tr><td>End-diastolic volume (mL)<sup>1</sup>
</td><td char="&#x000b1;" align="char">154.35&#x02009;&#x000b1;&#x02009;30.72</td></tr><tr><td>End-systolic volume (mL)<sup>1</sup>
</td><td char="&#x000b1;" align="char">85.14&#x02009;&#x000b1;&#x02009;29.55</td></tr><tr><td>Ejection Fraction (%)<sup>1</sup>
</td><td char="&#x000b1;" align="char">45.83&#x02009;&#x000b1;&#x02009;11.47</td></tr><tr><td>Infarct mass (gr)<sup>1</sup>
</td><td char="&#x000b1;" align="char">24.12&#x02009;&#x000b1;&#x02009;16.15</td></tr><tr><td>
<italic><underline>Chronic MRI</underline></italic>
</td><td/></tr><tr><td>End-diastolic volume (mL)<sup>1</sup>
</td><td char="&#x000b1;" align="char">161.65&#x02009;&#x000b1;&#x02009;30.73</td></tr><tr><td>End-systolic volume (mL)<sup>1</sup>
</td><td char="&#x000b1;" align="char">79.12&#x02009;&#x000b1;&#x02009;28.13</td></tr><tr><td>Ejection Fraction (%)<sup>1</sup>
</td><td char="&#x000b1;" align="char">52.16&#x02009;&#x000b1;&#x02009;10.82</td></tr><tr><td>Infarct mass (gr)<sup>1</sup>
</td><td char="&#x000b1;" align="char">13.74&#x02009;&#x000b1;&#x02009;10.46</td></tr><tr><td>
<bold>Medication use</bold>
</td><td/></tr><tr><td>IIB-IIIA inhibitor</td><td>58 (96.67%)</td></tr><tr><td>Antiplatelet (aspirine and/or clopidogrel)</td><td>58 (96.67%)</td></tr><tr><td>&#x003b2;-Blocker</td><td>58 (96.67%)</td></tr><tr><td>ACE inhibitor</td><td>51 (85%)</td></tr><tr><td>Statin</td><td>56 (94%)</td></tr></tbody></table><table-wrap-foot><p>Data expressed as mean (percentages). <sup>1</sup>Data expressed as mean and standard deviation.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Kinetics of Gd-DTPA by ss-IR sequences: <italic>acute versus chronic CMR</italic></title><sec id="Sec10"><title>Inversion time, signal-to-noise and contrast-to-noise ratios</title><p>A significant increase in IT was observed after the bolus contrast injection; however, no differences were observed in IT at each time point in the <italic>acute</italic> compared to the <italic>chronic</italic> CMRs (p&#x02009;&#x0003e;&#x02009;0.1 for all comparisons) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Relationship between the inversion time in the acute and chronic CMR over time after contrast administration</p></caption><graphic xlink:href="12968_2015_139_Fig1_HTML" id="MO1"/></fig></p><p>In <italic>acute</italic> CMR, after the injection of Gd-DTPA, the mean signal intensity in the infarct region was 495.45&#x02009;&#x000b1;&#x02009;8.35% higher than the remote region. Signal intensity increased slightly over several minutes, but was not statistically significant (p&#x02009;=&#x02009;0.727) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). Thus, no significant change occurred in the signal-to-noise (p&#x02009;=&#x02009;0.137) and contrast-to-noise ratios (p&#x02009;=&#x02009;0.140). Similar findings were observed in the signal-to-noise and contrast-to-noise ratios in <italic>chronic</italic> CMR, with no differences in their values, p&#x02009;=&#x02009;0.873 and p&#x02009;=&#x02009;0.706, respectively (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Relationship between the signal intensity in the left ventricular (LV) cavity, the infarcted and remote regions and the time after bolus injection in the acute <bold>(2A)</bold> and chronic CMR <bold>(2B)</bold>
</p></caption><graphic xlink:href="12968_2015_139_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec11"><title>LGE volume and relative LGE volume</title><p>In the analysis of infarct size, an intraclass correlation coefficient of 0.94 was found (95% confidence interval (CI): 0.88-0.96; p&#x02009;&#x0003c;&#x02009;0.0001) for interobserver and 0.98 (95% CI: 0.96-0.99; p&#x02009;&#x0003c;&#x02009;0.0001) for intraobserver variabilities.</p><p>Using ss-IR sequences, a significant dynamic change in LGE volume (p&#x02009;=&#x02009;0.005) and relative LGE volume (p&#x02009;=&#x02009;0.005) over several minutes after contrast administration was observed. The largest increase in LGE volume was between the 1st and 3rd minutes, and LGE volume subsequently decreased in <italic>acute CMR</italic>. A decrease of 4.91&#x02009;&#x000b1;&#x02009;9.08 grams, 22.20% relative reduction between the 3rd and 25th minutes, p&#x02009;=&#x02009;0.001 was observed (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A</xref>). Representative images are shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3C</xref>. Nevertheless, LGE volume remained constant over time in <italic>chronic CMR</italic> with no significant differences after contrast administration (p&#x02009;=&#x02009;0.886) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A</xref>). There were no differences in the mean infarct mass regarding the day at which the CMR was performed (p&#x02009;=&#x02009;0.066). However, this dynamic pattern was observed regardless of the day at which the CMR was performed.<table-wrap id="Tab2"><label>Table 2</label><caption><p>LGE and MVO volumes at different time points after the administration of the contrast in acute and chronic CMR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Minutes</th><th>Acute LGE volume (grams)</th><th>Acute MVO volume (grams)</th><th>Chronic LGE volume (grams)</th></tr></thead><tbody><tr><td>1st</td><td>22.49&#x02009;&#x000b1;&#x02009;15.13</td><td>6.31&#x02009;&#x000b1;&#x02009;10.92</td><td>10.68&#x02009;&#x000b1;&#x02009;7.48</td></tr><tr><td>3rd</td><td>25.99&#x02009;&#x000b1;&#x02009;14.64</td><td>5.07&#x02009;&#x000b1;&#x02009;10.46 (19.51%)*</td><td>11.29&#x02009;&#x000b1;&#x02009;6.86</td></tr><tr><td>5th</td><td>24.13&#x02009;&#x000b1;&#x02009;14.32</td><td>3.98&#x02009;&#x000b1;&#x02009;8.26 (36.93%)*</td><td>11.99&#x02009;&#x000b1;&#x02009;7.93</td></tr><tr><td>7th</td><td>23.86&#x02009;&#x000b1;&#x02009;14.43</td><td>3.50&#x02009;&#x000b1;&#x02009;8.20 (44.53%)*</td><td>11.77&#x02009;&#x000b1;&#x02009;8.39</td></tr><tr><td>10th</td><td>22.67&#x02009;&#x000b1;&#x02009;13.77</td><td>2.77&#x02009;&#x000b1;&#x02009;7.42 (56.10%)*</td><td>12.02&#x02009;&#x000b1;&#x02009;8.17</td></tr><tr><td>15th</td><td>22.20&#x02009;&#x000b1;&#x02009;13.61</td><td>2.05&#x02009;&#x000b1;&#x02009;6.40 (67.52%)*</td><td>11.75&#x02009;&#x000b1;&#x02009;7.81</td></tr><tr><td>20th</td><td>21.19&#x02009;&#x000b1;&#x02009;12.62</td><td>1.81&#x02009;&#x000b1;&#x02009;6.66 (71.32%)*</td><td>10.92&#x02009;&#x000b1;&#x02009;7.12</td></tr><tr><td>25th</td><td>20.22&#x02009;&#x000b1;&#x02009;12.41</td><td>0.79&#x02009;&#x000b1;&#x02009;2.67 (87.32%)*</td><td>10.75&#x02009;&#x000b1;&#x02009;7.21</td></tr></tbody></table><table-wrap-foot><p>Data expressed as mean and standard deviation. *Data expressed as percentage of reduction.</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Dynamic changes of late Gadolinium enhancement volume over time after contrast injection in acute and chronic CMR <bold>(3A)</bold> and also in the presence of early and late microvascular obstruction <bold>(3B)</bold>. Representative images of the changes in late Gadolinium and microvascular obstruction volumes in 3 patients (each patient is represented in a row) at different time points (3, 10 and 25&#x000a0;minutes after the administration of the contrast) <bold>(3C)</bold>
</p></caption><graphic xlink:href="12968_2015_139_Fig3_HTML" id="MO3"/></fig></p><p><italic>Early MVO</italic> was seen in 35 patients (58%) and <italic>late MVO</italic> in 16 (27%), all of whom also had <italic>early</italic> MVO. MVO was not present in the <italic>chronic</italic> CMR studies. A significant decrease was observed in MVO volume (p&#x02009;=&#x02009;0.005) with the greatest volume 1&#x000a0;minute after contrast administration and the smallest after 25&#x000a0;minutes (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Dynamic changes in LGE volume also occurred regardless of the presence of <italic>early or late MVO</italic>. Patients with <italic>late MVO</italic> presented slower wash-in of Gd-DTPA with a maximum LGE volume at 7&#x000a0;minutes post-contrast injection compared with the 3&#x000a0;minutes observed in patients with <italic>early MVO</italic> (<italic>early MVO:</italic> p&#x02009;=&#x02009;0.022 and <italic>late MVO</italic>: p&#x02009;=&#x02009;0.046) (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>).</p></sec><sec id="Sec12"><title>LGE transmurality and LGE lateral extension</title><p>In <italic>acute</italic> CMR, a drop in LGE transmurality was observed over time with an increase for the first 3&#x000a0;minutes and with a subsequent decrease (following the same pattern as LGE volume over time) (p&#x02009;=&#x02009;0.05). However, the infarct-ESA remained stable over time, thereby suggesting that the change in LGE size was due to a decrease in its transmurality rather than in its lateral extension (p&#x02009;=&#x02009;0.981) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Dynamic changes of the transmurality index and the infarct-ESA over time after contrast administration</p></caption><graphic xlink:href="12968_2015_139_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec13"><title>Different sequences to assess contrast enhancement</title><sec id="Sec14"><title>LGE size: ss-IR versus seg-IR sequences</title><p>In <italic>acute</italic> CMR studies, each image obtained by the seg-IR sequence was compared with its homologous ss-IR at the same slice position and same time point. Mean LGE size by ss-IR (3.57&#x02009;&#x000b1;&#x02009;1.96&#x000a0;g) did not differ statistically from the seg-IR (3.48&#x02009;&#x000b1;&#x02009;1.91&#x000a0;g), p&#x02009;=&#x02009;0.72. Intraclass correlation coefficients between ss-IR and seg-IR were 0.92 (95% CI: 0.89-0.94; p&#x02009;&#x0003c;&#x02009;0.0001). Bland-Altman analysis showed a bias of 0.09 grams of LGE size (95% CI: 0.05, 0.23).</p></sec><sec id="Sec15"><title>LGE volume and different standard deviations over remote signal intensity</title><p>The LGE size obtained by ss-IR sequences was analyzed using different thresholds (2, 3, 4 and 5 SD over remote signal intensity) and no manual planimetry correction. A reduction in mean LGE size was observed when the SD was increased in both <italic>acute</italic> (p&#x02009;=&#x02009;0.019) and <italic>chronic</italic> settings (p&#x02009;=&#x02009;0.039) (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The slopes of both curves were similar, which suggested that increasing the threshold and thus changing the method of quantifying LGE size would result in smaller LGE sizes in the same proportion for acute and chronic settings.<fig id="Fig5"><label>Fig. 5</label><caption><p>Late Gadolinium enhancement volume obtained by single-shot sequences analyzed using different thresholds (2, 3, 4 and 5 standard deviation over remote signal intensity) in acute and chronic CMR</p></caption><graphic xlink:href="12968_2015_139_Fig5_HTML" id="MO5"/></fig></p></sec></sec><sec id="Sec16"><title>Effect of timing of LGE measurement to estimate the transmurality index and the recovery of left ventricular function</title><p>A dynamic change on the transmural index and the number of patients at a certain degree of transmurality (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) was observed. Thus, 10&#x000a0;min post-contrast, 15 patients (25%) presented a transmural index&#x02009;&#x02265;&#x02009;75%, however, only 7 patients (11.67%) at 25&#x000a0;minutes.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Change of the transmurality index over time (in minutes) after the administration of the contrast in acute CMR</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5">Transmurality index</th></tr></thead><tbody><tr><td>
<bold>Time</bold>
</td><td>
<bold>&#x0003c;25%</bold>
</td><td>
<bold>25-50%</bold>
</td><td>
<bold>51-75%</bold>
</td><td>
<bold>&#x0003e;75%</bold>
</td></tr><tr><td>
<bold>1&#x000a0;min</bold>
</td><td>8 (13.33%)</td><td>13 (21.67%)</td><td>21 (35%)</td><td>18 (30%)</td></tr><tr><td>
<bold>3&#x000a0;min</bold>
</td><td>2 (3.33%)</td><td>10(16.67%)</td><td>24 (40%)</td><td>24 (40%)</td></tr><tr><td>
<bold>5&#x000a0;min</bold>
</td><td>2 (3.33%)</td><td>9 (15%)</td><td>32 (53.33%)</td><td>17 (28.33%)</td></tr><tr><td>
<bold>7&#x000a0;min</bold>
</td><td>1 (1.67%)</td><td>12 (20%)</td><td>30 (50%)</td><td>17 (28.33%)</td></tr><tr><td>
<bold>10&#x000a0;min</bold>
</td><td>1 (1.67%)</td><td>15 (25%)</td><td>29 (48.33%)</td><td>15 (25%)</td></tr><tr><td>
<bold>15&#x000a0;min</bold>
</td><td>1 (1.67%)</td><td>14 (23.33%)</td><td>32 (53.33%)</td><td>13 (21.67%)</td></tr><tr><td>
<bold>20&#x000a0;min</bold>
</td><td>1 (1.67%)</td><td>19 (31.67%)</td><td>30 (50%)</td><td>10 (16.67%)</td></tr><tr><td>
<bold>25&#x000a0;min</bold>
</td><td>1 (1.67%)</td><td>21 (35%)</td><td>31 (51.67%)</td><td>7 (11.67%)</td></tr></tbody></table><table-wrap-foot><p>Data expressed as number of patients with a certain degree of transmurality index (percentages). Min&#x02009;=&#x02009;minutes.</p></table-wrap-foot></table-wrap></p><p>These dynamic changes were also observed in the myocardial segmental recovery of function. Thus, in patients with a transmural index&#x02009;&#x0003e;&#x02009;75% 10&#x000a0;min post-contrast, 3.25&#x02009;&#x000b1;&#x02009;2.76 segments improved their function and the wall motion score index improved 4.00&#x02009;&#x000b1;&#x02009;4.78 in the chronic CMR. However, in patients with a transmural index&#x02009;&#x0003e;&#x02009;75% 25&#x000a0;min post-contrast, only 2.00&#x02009;&#x000b1;&#x02009;1.97 segments recovered its function and the wall motion score index improved only 2.00&#x02009;&#x000b1;&#x02009;3.50 (p&#x02009;=&#x02009;0.046 for segment recovery and p&#x02009;=&#x02009;0.028 for the wall motion score index) (Fig. <xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><p>6<bold>A</bold>: Variation of the wall motion score index (WMSI) from acute CMR to chronic CMR according to the degree of transmurality (assessed 10 or 25&#x000a0;minutes after the contrast injection). Note that there is a significant improvement in the WMSI at follow-up except when the transmurality index is&#x02009;&#x0003e;&#x02009;75% and assessed at 25&#x000a0;minutes. 6<bold>B</bold>/6<bold>C</bold>/6<bold>D</bold>: End-diastolic <bold>(B)</bold>, end-systolic <bold>(C)</bold> volumes and ejection fraction <bold>(D)</bold> at follow-up according to the degree of transmurality assessed in the acute CMR at 10 and 25&#x000a0;min post-contrast. Note that only patients with a transmurality index&#x02009;&#x0003e;&#x02009;75% measured 25&#x000a0;minutes post-contrast present a significant increase in the end-diastolic and end-systolic volumes and a significant decrease in the ejection fraction at follow-up. rohandkumar1@ucla.edu</p></caption><graphic xlink:href="12968_2015_139_Fig6_HTML" id="MO6"/></fig></p><p>Finally, patients with a transmural index&#x02009;&#x0003e;&#x02009;75% in the acute CMR 25&#x000a0;minutes post-contrast presented higher increase of EDV (p&#x02009;=&#x02009;0.039), ESV (p&#x02009;&#x0003c;&#x02009;0.001) and a higher decrease of EF (p&#x02009;&#x0003c;&#x02009;0.001) at follow-up compared to those patients to whom the transmural index&#x02009;&#x0003e;&#x02009;75% was determined 10&#x000a0;minutes post-contrast. (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Variation of CMR variables at follow-up in patients with a transmurality index&#x02009;&#x0003e;&#x02009;75% (in the acute CMR) at different minutes post-contrast</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Time</th><th>N</th><th>&#x00394; WMSI</th><th>&#x00394; Num segments</th><th>&#x00394; EDV (%)</th><th>&#x00394; ESV (%)</th><th>&#x00394; EF (%)</th></tr></thead><tbody><tr><td>
<bold>1&#x000a0;min</bold>
</td><td>18 (30%)<sup>1</sup>
</td><td>2.90&#x02009;&#x000b1;&#x02009;3.60</td><td>2.30&#x02009;&#x000b1;&#x02009;2.21</td><td>12.73&#x02009;&#x000b1;&#x02009;21.99</td><td>13.21&#x02009;&#x000b1;&#x02009;43.06</td><td>&#x02212;4.48&#x02009;&#x000b1;&#x02009;31.23</td></tr><tr><td>
<bold>3&#x000a0;min</bold>
</td><td>24 (40%)<sup>1</sup>
</td><td>4.93&#x02009;&#x000b1;&#x02009;4.68</td><td>4.90&#x02009;&#x000b1;&#x02009;2.56</td><td>9.87&#x02009;&#x000b1;&#x02009;22.78</td><td>3.44&#x02009;&#x000b1;&#x02009;40.08</td><td>3.48&#x02009;&#x000b1;&#x02009;28.79</td></tr><tr><td>
<bold>5&#x000a0;min</bold>
</td><td>17 (28.33%)<sup>1</sup>
</td><td>4.20&#x02009;&#x000b1;&#x02009;3.01</td><td>4.80&#x02009;&#x000b1;&#x02009;1.85</td><td>15.67&#x02009;&#x000b1;&#x02009;22.55</td><td>15.84&#x02009;&#x000b1;&#x02009;45.52</td><td>&#x02212;0.47&#x02009;&#x000b1;&#x02009;33.72</td></tr><tr><td>
<bold>7&#x000a0;min</bold>
</td><td>17 (28.33%)<sup>1</sup>
</td><td>4.12&#x02009;&#x000b1;&#x02009;4.36</td><td>4.55&#x02009;&#x000b1;&#x02009;2.31</td><td>14.01&#x02009;&#x000b1;&#x02009;28.71</td><td>14.79&#x02009;&#x000b1;&#x02009;44.85</td><td>&#x02212;2.59&#x02009;&#x000b1;&#x02009;33.49</td></tr><tr><td>
<bold>10&#x000a0;min</bold>
</td><td>15 (25%)<sup>1</sup>
</td><td>4.00&#x02009;&#x000b1;&#x02009;4.78</td><td>4.25&#x02009;&#x000b1;&#x02009;2.76</td><td>14.64&#x02009;&#x000b1;&#x02009;25.56</td><td>11.08&#x02009;&#x000b1;&#x02009;40.57</td><td>&#x02212;2.01&#x02009;&#x000b1;&#x02009;33.66</td></tr><tr><td>
<bold>15&#x000a0;min</bold>
</td><td>13 (21.67%)<sup>1</sup>
</td><td>3.60&#x02009;&#x000b1;&#x02009;5.03</td><td>3.20&#x02009;&#x000b1;&#x02009;2.59</td><td>17.47&#x02009;&#x000b1;&#x02009;24.60</td><td>17.05&#x02009;&#x000b1;&#x02009;40.38</td><td>&#x02212;4.38&#x02009;&#x000b1;&#x02009;36.16</td></tr><tr><td>
<bold>20&#x000a0;min</bold>
</td><td>10 (16.67%)<sup>1</sup>
</td><td>2.60&#x02009;&#x000b1;&#x02009;3.78</td><td>2.60&#x02009;&#x000b1;&#x02009;1.67</td><td>20.47&#x02009;&#x000b1;&#x02009;30.93</td><td>24.81&#x02009;&#x000b1;&#x02009;45.67</td><td>&#x02212;8.75&#x02009;&#x000b1;&#x02009;39.56</td></tr><tr><td>
<bold>25&#x000a0;min</bold>
</td><td>7 (11.67%)<sup>1</sup>
</td><td>2.00&#x02009;&#x000b1;&#x02009;3.50</td><td>2.00&#x02009;&#x000b1;&#x02009;1.97</td><td>22.72&#x02009;&#x000b1;&#x02009;27.52</td><td>26.15&#x02009;&#x000b1;&#x02009;40.31</td><td>&#x02212;10.27&#x02009;&#x000b1;&#x02009;40.40</td></tr></tbody></table><table-wrap-foot><p>N: expresses the number of patients with a transmurality index&#x02009;&#x0003e;&#x02009;75% in the acute CMR. &#x00394;: expresses the change of the variables from the acute to the chronic CMR.</p><p>Data expressed as mean and standard deviation.<sup>1</sup>Data expressed as mean (percentages).</p><p>Min: minutes. WMSI: Wall motion score index. Num: number. EDV: end-diastolic volume. ESV: end-systolic volume. EF: ejection fraction.</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec17" sec-type="discussion"><title>Discussion</title><p>We report the first detailed time course study, examining LGE in the setting of an acute and chronic MI in the same cohort of patients treated with primary PCI for STEMI. More importantly, we found that the timing and delay of viability imaging acquisition, following contrast administration, is vitally important in predicting global and segmental left ventricular recovery. This dynamic distribution of LGE is consistent with previous experimental and clinical studies [<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>The main findings in our study are that 1) the distribution of Gadolinium within the infarcted area constitutes a dynamic process, with a maximum volume 3&#x000a0;minutes after contrast administration and subsequent decreases over time; 2) these changes are present in the acute setting but not in chronic MI; 3) changes in LGE size is due to a decrease in the transmural extension (within the area at risk) rather than the lateral borders; 4) dynamics of Gadolinium also occur if MVO is present, in this case, a slower rate of wash-out is observed.</p><sec id="Sec18"><title>Kinetics of Gadolinium-DTPA in the infarct and the peri-infarct zone</title><p>Different mechanisms have been proposed to account for the Gd-DTPA enhancement patterns seen in reperfused infarcted tissue and the peri-infarct zone. First, there is an increase in the extracellular volume due to interstitial edema and/or loss of cell membrane integrity, which would increase the volume of distribution of Gd-DTPA. These findings were confirmed by Arheden et al., who found that the distribution volume was higher in the infarcted myocardium and intermediate in the peri-infarct zone compared to remote myocardium, and increased significantly with prolongation of the ischemic period [<xref ref-type="bibr" rid="CR22">22</xref>]. Also, Klein et al. showed that the increase in the volume of distribution was the mechanism for an increase in necrosis signal intensity as the partition coefficient (&#x003bb;) was elevated compared to remote myocardium [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p>Another hypothesis is that injured myocardium may also have abnormal Gadolinium wash-in and wash-out kinetics due to various factors (changes in coronary flow rates, capillary permeability, or functional capillary density). Slow wash-in, in reperfused infarcted regions, would lead to early low tissue contrast concentrations, whereas slow wash-out would eventually lead to higher contrast concentrations compared with normal tissue [<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR7">7</xref>]. In this setting, Kim et al. found that in normal regions, contrast wash-in and wash-out were rapidly reaching a steady state within 2&#x02013;3 minutes. Rim regions presented a significant delay in contrast kinetics compared to the normal, but not to the necrotic, myocardium. Contrast kinetics in core regions were so slow that signal intensity did not reach a steady state after 30&#x000a0;minutes [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>The fact that Gadolinium accumulates in the peri-infarct zone of reversibly injured myocardium tissue could explain our findings. This hypothesis is supported by the fact that these dynamic changes are only seen in the acute setting, where edema and necrotic myocytes are present, and not in chronic infarcts with a dense collagenous matrix. Moreover, as we have demonstrated, the reduction of the infarct size is due to a decrease in the transmural extension rather than at the lateral borders after a coronary occlusion. Reimer and Jennings [<xref ref-type="bibr" rid="CR24">24</xref>] and others [<xref ref-type="bibr" rid="CR25">25</xref>] demonstrated that myocytes necrosis occupy the entire subendocardial surface of the area at risk and the irreversible injury progresses as a &#x0201c;wave-front&#x0201d; towards the subepicardium.</p></sec><sec id="Sec19"><title>Dynamic changes of infarct size and left ventricular function</title><p>Classical studies have shown that the transmural extent of infarction as defined by CMR predicts improvement in contractile function in acute and chronic MI [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>]. However, discordant results have been reported. Using tagging sequences at baseline and during low dose dobutamine infusion, Kramer et al. [<xref ref-type="bibr" rid="CR8">8</xref>] concluded that transmural LGE overestimated irreversible injury in acute MI. Also, Beek et al. [<xref ref-type="bibr" rid="CR26">26</xref>] reported that 25% of segments with transmural LGE after an acute MI might potentially improve their function after 13&#x000a0;weeks. Similar findings have been reported by Dall&#x02019;Armellina et al. [<xref ref-type="bibr" rid="CR27">27</xref>], concluding that the acutely detected LGE does not necessarily equate with irreversible injury and may severely underestimate salvaged myocardium. In these studies, LGE was acquired 5&#x02013;10 minutes after the contrast administration.</p><p>Although our and other studies [<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR5">5</xref>] support the hypothesis that LGE can occur in reversibly-injured myocardial tissue in acute MI, studies in animals with acute MI have shown that LGE only occurs in irreversibly-injured tissue [<xref ref-type="bibr" rid="CR3">3</xref>]. Close inspection of the methodology of these studies reveals some differences that should be considered: 1) Different sequences have been used to assess LGE images. 2) The time after contrast injection and image acquisition can vary from 5 to 30&#x000a0;minutes. 3) There can be differences between different species. Thus, Oshinski et al. found that the true infarct size, as assessed by TTC-staining, was overestimated by 20% to 40% immediately after contrast injection and that the time for the enhanced region to correspond to the true infarct size was at 21&#x02009;&#x000b1;&#x02009;4&#x000a0;minutes [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>Nevertheless, when the LGE is performed 20&#x000a0;minutes after the contrast injection the transmural extent of LGE correlated inversely with wall thickening and the ejection fraction both in the acute phase and at follow-up [<xref ref-type="bibr" rid="CR29">29</xref>]. These results are concordant with our findings where using the transmurality index at 25&#x000a0;minutes correlated with a non-significant improvement of the WMSI and an adverse left ventricular remodeling at follow-up compared to patients with a transmural infarction estimated 10&#x000a0;minutes after contrast injection.</p></sec><sec id="Sec20"><title>Microvascular obstruction</title><p>MVO in LGE imaging has been reported to occur in 28% to 58% of patients after STEMI [<xref ref-type="bibr" rid="CR17">17</xref>]. Klein et al. also found that the pattern of wash-in and wash-out was severely reduced in areas with marked MVO in images 18&#x000a0;minutes post contrast [<xref ref-type="bibr" rid="CR23">23</xref>]. Similar findings were found in our study, thus, in patients with <italic>late MVO</italic>, dynamic changes of LGE were delayed compared to patients with smaller areas of MVO. Moreover, we demonstrate a rapid decline in the presence and volume of MVO in the minutes following contrast administration. This fact is of paramount importance as these rapid changes can potentially bias studies evaluating interventional trials aimed in reducing MVO. Nevertheless, due to the reduced number of patients in each group we could not find statistically significant differences and this finding should be further investigated.</p></sec><sec id="Sec21"><title>Delayed enhancement CMR sequences and technical aspects</title><p>The segmented technique has been used as the gold standard for the detection of myocardial infarction and accurate assessment of viability [<xref ref-type="bibr" rid="CR13">13</xref>]. However, Huber et al. [<xref ref-type="bibr" rid="CR12">12</xref>] described a new fast multislice technique, the single-shot sequence with an excellent correlation with the segmented to assess the size of the infarcted myocardium. This sequence allows imaging of nine slices during one breath-hold and, therefore, has the advantage of shortening scanning times, making it suitable for use with uncooperative patients.</p><p>A mixed T1 and T2 contrast is known for single-shot sequences [<xref ref-type="bibr" rid="CR12">12</xref>]. As a result, the area of infarction could be overestimated in patients with an acute MI because of the edema and may justify the dynamic changes of LGE observed in <italic>acute CMR</italic>. Nevertheless, this hypothesis cannot be supported for many reasons: 1) the parameters used in the single-shot sequence (the inversion pulse, a short TR and TE, and a flip angle of 50&#x000b0;) support the T1 contrast compared with the T2 contrast. 2) The area of infarction is not overestimated on the ss-IR sequence when compared with the seg-IR at the same slice position.</p><p>The methodology used to measure LGE sequences is one of the most important points to consider in order to accurately quantify the size of MI. Kim et al. validated that LGE closely tracks the area of irreversible myocardial injury using an intensity thresholding of 2 SD above the mean of the normal myocardial intensity [<xref ref-type="bibr" rid="CR3">3</xref>]. Although newer automated methods have been developed [<xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref>], there is no consensus for a precise method to automatically assess the real infarct size. In our study, we adopted the methodology of 2SD for both acute and chronic infarct mass, thus, the dynamic change of LGE volumes over time has been determined. Also, in our analysis, increasing the SD thresholds resulted in smaller infarct volumes in the same proportion for acute and chronic scars. However, the use of different SD is arbitrary and for that reason the use of T1 mapping sequences with a more quantitative assessment of the T1-values of the myocardium at different time points could potentially confirm more objectively our results.</p></sec><sec id="Sec22"><title>Limitations</title><p>Currently, the contrast kinetics following 25&#x000a0;minutes are unknown. However, due to the stability of infarct mass 20 to 25&#x000a0;minutes after the administration of the contrast and the specificity of the transmurality index at 25&#x000a0;minutes to predict the functional recovery at follow-up, we do not expect that longer periods of time would imply significant differences in our results.</p><p>Although our study suggests that the volume of LGE 3&#x000a0;minutes after contrast injection should correlate the AAR (early contrast enhancement) and the infarct size 25&#x000a0;minutes after (late contrast enhancement), we did not perform T2-weighted images to compare our findings. However, using the same patient population we have previously demonstrated a good correlation within the Infarct-ESA and the BARI score to assess the AAR [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec></sec><sec id="Sec23" sec-type="conclusion"><title>Conclusion</title><p>There is a change in LGE size over time in acute human reperfused STEMI not seen in the chronic phase, with a maximum size 3&#x000a0;minutes after the contrast administration and a decrease thereafter. This reduction occurs within the area at risk (transmural extension) rather than in the lateral boundaries.</p><p>It is important to wait at least 25&#x000a0;minutes to ensure a more accurate determination of infarct size in acute but not in chronic infarcts, in order to better predict left ventricular recovery at follow-up.</p><p>We consider that these findings have important implications and should be considered in clinical trials that consider infarct size and infarct transmurality as end-points or to predict global or regional recovery.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CMR</term><def><p>Cardiovascular magnetic resonance</p></def></def-item><def-item><term>LGE</term><def><p>Late Gadolinium enhancement</p></def></def-item><def-item><term>TTC</term><def><p>Triphenyltetrazolium chloride staining</p></def></def-item><def-item><term>MI</term><def><p>Myocardial infarction</p></def></def-item><def-item><term>STEMI</term><def><p>ST-segment elevation myocardial infarction</p></def></def-item><def-item><term>PCI</term><def><p>Percutaneous coronary intervention</p></def></def-item><def-item><term>LV</term><def><p>Left ventricle</p></def></def-item><def-item><term>EDV</term><def><p>End-diastolic volume</p></def></def-item><def-item><term>ESV</term><def><p>End-systolic volume</p></def></def-item><def-item><term>EF</term><def><p>Ejection fraction</p></def></def-item><def-item><term>WMSI</term><def><p>Wall motion score index</p></def></def-item><def-item><term>MVO</term><def><p>Microvascular obstruction</p></def></def-item><def-item><term>SD</term><def><p>Standard deviation</p></def></def-item><def-item><term>Gd-DTPA</term><def><p>Gadolinium-DTPA</p></def></def-item><def-item><term>SS-IR</term><def><p>Single-shot inversion recovery steady-state free precession sequence</p></def></def-item><def-item><term>Seg-IR</term><def><p>Segmented inversion-recovery gradient-echo sequence</p></def></def-item><def-item><term>Infarct-ESA</term><def><p>Infarct endocardial surface area</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>There are no competing interests to disclose among the authors.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>This is the specific contribution of each author. JFRP: Analysis and interpretation of data, drafting of manuscript, critical revision and final approval of the manuscript. JTOP: Analysis and interpretation of data, critical revision and final approval of the manuscript. DCL: Analysis and interpretation of data, critical revision and final approval of the manuscript. CBD: Analysis and interpretation of data, critical revision and final approval of the manuscript. PT: Analysis and interpretation of data, critical revision and final approval of the manuscript. ROB: Conception and design, analysis and interpretation of data, critical revision and final approval of the manuscript. EW: Conception and design, analysis and interpretation of data, critical revision and final approval of the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We acknowledge Christine O&#x02019;Hara for her contribution to the review of this manuscript. JFRP was supported by a Grant post-residency of the Spanish Society of Cardiology (2006). JTOP was supported by the Esteve Research Grant for Investigation in the United States (2004) and the Working Group on Ischemic Cardiomyopathy Grant (2005) of the Spanish Society of Cardiology.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>KM</given-names></name><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Gubernikoff</surname><given-names>G</given-names></name><name><surname>Vargas</surname><given-names>JD</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name></person-group><article-title>Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function</article-title><source>Circulation</source><year>2001</year><volume>104</volume><issue>10</issue><fpage>1101</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/hc3501.096798</pub-id><pub-id pub-id-type="pmid">11535563</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Rafael</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>EL</given-names></name><name><surname>Parker</surname><given-names>MA</given-names></name><name><surname>Simonetti</surname><given-names>O</given-names></name><etal/></person-group><article-title>The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><issue>20</issue><fpage>1445</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1056/NEJM200011163432003</pub-id><pub-id pub-id-type="pmid">11078769</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Fieno</surname><given-names>DS</given-names></name><name><surname>Parrish</surname><given-names>TB</given-names></name><name><surname>Harris</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>EL</given-names></name><name><surname>Simonetti</surname><given-names>O</given-names></name><etal/></person-group><article-title>Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function</article-title><source>Circulation</source><year>1999</year><volume>100</volume><issue>19</issue><fpage>1992</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.100.19.1992</pub-id><pub-id pub-id-type="pmid">10556226</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Albert</surname><given-names>TS</given-names></name><name><surname>Wible</surname><given-names>JH</given-names></name><name><surname>Elliott</surname><given-names>MD</given-names></name><name><surname>Allen</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>5</issue><fpage>629</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.723262</pub-id><pub-id pub-id-type="pmid">18212288</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshinski</surname><given-names>JN</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Jones</surname><given-names>JR</given-names></name><name><surname>Mata</surname><given-names>JF</given-names></name><name><surname>French</surname><given-names>BA</given-names></name></person-group><article-title>Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging</article-title><source>Circulation</source><year>2001</year><volume>104</volume><issue>23</issue><fpage>2838</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1161/hc4801.100351</pub-id><pub-id pub-id-type="pmid">11733404</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>M</given-names></name><name><surname>Bremerich</surname><given-names>J</given-names></name><name><surname>Wendland</surname><given-names>MF</given-names></name><name><surname>Wyttenbach</surname><given-names>R</given-names></name><name><surname>Weinmann</surname><given-names>HJ</given-names></name><name><surname>Higgins</surname><given-names>CB</given-names></name></person-group><article-title>Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats</article-title><source>Radiology</source><year>1999</year><volume>213</volume><issue>1</issue><fpage>247</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1148/radiology.213.1.r99se30247</pub-id><pub-id pub-id-type="pmid">10540668</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>EL</given-names></name><name><surname>Lima</surname><given-names>JA</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name></person-group><article-title>Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction</article-title><source>Circulation</source><year>1996</year><volume>94</volume><issue>12</issue><fpage>3318</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.94.12.3318</pub-id><pub-id pub-id-type="pmid">8989146</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>CM</given-names></name><name><surname>Rogers</surname><given-names>WJ</given-names><suffix>Jr</suffix></name><name><surname>Mankad</surname><given-names>S</given-names></name><name><surname>Theobald</surname><given-names>TM</given-names></name><name><surname>Pakstis</surname><given-names>DL</given-names></name><name><surname>Hu</surname><given-names>YL</given-names></name></person-group><article-title>Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction</article-title><source>J Am Coll Cardiol</source><year>2000</year><volume>36</volume><issue>6</issue><fpage>1835</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(00)00945-1</pub-id><pub-id pub-id-type="pmid">11092653</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>WJ</given-names><suffix>Jr</suffix></name><name><surname>Kramer</surname><given-names>CM</given-names></name><name><surname>Geskin</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>YL</given-names></name><name><surname>Theobald</surname><given-names>TM</given-names></name><name><surname>Vido</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction</article-title><source>Circulation</source><year>1999</year><volume>99</volume><issue>6</issue><fpage>744</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.99.6.744</pub-id><pub-id pub-id-type="pmid">9989958</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H</given-names></name><name><surname>Matsuda</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>K</given-names></name><name><surname>Shimada</surname><given-names>T</given-names></name><name><surname>Mikuri</surname><given-names>M</given-names></name><name><surname>Hiraoka</surname><given-names>Y</given-names></name></person-group><article-title>Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction</article-title><source>JACC Cardiovasc Imaging</source><year>2011</year><volume>4</volume><issue>6</issue><fpage>610</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2011.03.015</pub-id><pub-id pub-id-type="pmid">21679895</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>AE</given-names></name></person-group><article-title>Gadolinium can depict area at risk and myocardial infarction: a double-edged sword?</article-title><source>JACC Cardiovasc Imaging</source><year>2011</year><volume>4</volume><issue>6</issue><fpage>619</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2011.04.006</pub-id><pub-id pub-id-type="pmid">21679896</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>A</given-names></name><name><surname>Schoenberg</surname><given-names>SO</given-names></name><name><surname>Spannagl</surname><given-names>B</given-names></name><name><surname>Rieber</surname><given-names>J</given-names></name><name><surname>Erhard</surname><given-names>I</given-names></name><name><surname>Klauss</surname><given-names>V</given-names></name><etal/></person-group><article-title>Single-shot inversion recovery TrueFISP for assessment of myocardial infarction</article-title><source>AJR Am J Roentgenol</source><year>2006</year><volume>186</volume><issue>3</issue><fpage>627</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.2214/AJR.04.0746</pub-id><pub-id pub-id-type="pmid">16498088</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonetti</surname><given-names>OP</given-names></name><name><surname>Kim</surname><given-names>RJ</given-names></name><name><surname>Fieno</surname><given-names>DS</given-names></name><name><surname>Hillenbrand</surname><given-names>HB</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Bundy</surname><given-names>JM</given-names></name><etal/></person-group><article-title>An improved MR imaging technique for the visualization of myocardial infarction</article-title><source>Radiology</source><year>2001</year><volume>218</volume><issue>1</issue><fpage>215</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1148/radiology.218.1.r01ja50215</pub-id><pub-id pub-id-type="pmid">11152805</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name><name><surname>Vargas</surname><given-names>JD</given-names></name><name><surname>Klocke</surname><given-names>FJ</given-names></name><name><surname>Bonow</surname><given-names>RO</given-names></name><name><surname>Kim</surname><given-names>RJ</given-names></name></person-group><article-title>Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction</article-title><source>Lancet</source><year>2001</year><volume>357</volume><issue>9249</issue><fpage>21</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)03567-4</pub-id><pub-id pub-id-type="pmid">11197356</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokorney</surname><given-names>SD</given-names></name><name><surname>Rodriguez</surname><given-names>JF</given-names></name><name><surname>Ortiz</surname><given-names>JT</given-names></name><name><surname>Lee</surname><given-names>DC</given-names></name><name><surname>Bonow</surname><given-names>RO</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name></person-group><article-title>Infarct healing is a dynamic process following acute myocardial infarction</article-title><source>J Cardiovasc Magn Reson: Off J Soc Cardiovasc Magn Reson</source><year>2012</year><volume>14</volume><fpage>62</fpage><pub-id pub-id-type="doi">10.1186/1532-429X-14-62</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Zerhouni</surname><given-names>EA</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name><name><surname>Lugo-Olivieri</surname><given-names>CH</given-names></name><name><surname>Barouch</surname><given-names>LA</given-names></name><name><surname>Schulman</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction</article-title><source>Circulation</source><year>1998</year><volume>97</volume><issue>8</issue><fpage>765</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.97.8.765</pub-id><pub-id pub-id-type="pmid">9498540</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hombach</surname><given-names>V</given-names></name><name><surname>Grebe</surname><given-names>O</given-names></name><name><surname>Merkle</surname><given-names>N</given-names></name><name><surname>Waldenmaier</surname><given-names>S</given-names></name><name><surname>Hoher</surname><given-names>M</given-names></name><name><surname>Kochs</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging</article-title><source>Eur Heart J</source><year>2005</year><volume>26</volume><issue>6</issue><fpage>549</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehi147</pub-id><pub-id pub-id-type="pmid">15713695</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>JA</given-names></name><name><surname>Judd</surname><given-names>RM</given-names></name><name><surname>Bazille</surname><given-names>A</given-names></name><name><surname>Schulman</surname><given-names>SP</given-names></name><name><surname>Atalar</surname><given-names>E</given-names></name><name><surname>Zerhouni</surname><given-names>EA</given-names></name></person-group><article-title>Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI</article-title><source>Potential mechanisms Circulation</source><year>1995</year><volume>92</volume><issue>5</issue><fpage>1117</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.92.5.1117</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name><name><surname>Theroux</surname><given-names>P</given-names></name><name><surname>Elizaga</surname><given-names>J</given-names></name><name><surname>Galinanes</surname><given-names>M</given-names></name><name><surname>Solares</surname><given-names>J</given-names></name><name><surname>Riesgo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion</article-title><source>Cardiovascular Res</source><year>1987</year><volume>21</volume><issue>7</issue><fpage>537</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1093/cvr/21.7.537</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orn</surname><given-names>S</given-names></name><name><surname>Manhenke</surname><given-names>C</given-names></name><name><surname>Anand</surname><given-names>IS</given-names></name><name><surname>Squire</surname><given-names>I</given-names></name><name><surname>Nagel</surname><given-names>E</given-names></name><name><surname>Edvardsen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction</article-title><source>Am J Cardiol</source><year>2007</year><volume>99</volume><issue>8</issue><fpage>1109</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2006.11.059</pub-id><pub-id pub-id-type="pmid">17437737</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Perez</surname><given-names>JT</given-names></name><name><surname>Meyers</surname><given-names>SN</given-names></name><name><surname>Lee</surname><given-names>DC</given-names></name><name><surname>Kansal</surname><given-names>P</given-names></name><name><surname>Klocke</surname><given-names>FJ</given-names></name><name><surname>Holly</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging</article-title><source>Eur Heart J</source><year>2007</year><volume>28</volume><issue>14</issue><fpage>1750</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehm212</pub-id><pub-id pub-id-type="pmid">17586811</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arheden</surname><given-names>H</given-names></name><name><surname>Saeed</surname><given-names>M</given-names></name><name><surname>Higgins</surname><given-names>CB</given-names></name><name><surname>Gao</surname><given-names>DW</given-names></name><name><surname>Ursell</surname><given-names>PC</given-names></name><name><surname>Bremerich</surname><given-names>J</given-names></name><etal/></person-group><article-title>Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging</article-title><source>Radiology</source><year>2000</year><volume>215</volume><issue>2</issue><fpage>520</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1148/radiology.215.2.r00ma38520</pub-id><pub-id pub-id-type="pmid">10796935</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Schmal</surname><given-names>TR</given-names></name><name><surname>Nekolla</surname><given-names>SG</given-names></name><name><surname>Schnackenburg</surname><given-names>B</given-names></name><name><surname>Fleck</surname><given-names>E</given-names></name><name><surname>Nagel</surname><given-names>E</given-names></name></person-group><article-title>Mechanism of late gadolinium enhancement in patients with acute myocardial infarction</article-title><source>J Cardiovasc Magn Reson: Off J Soc Cardiovasc Magn Reson</source><year>2007</year><volume>9</volume><issue>4</issue><fpage>653</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1080/10976640601105614</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>KA</given-names></name><name><surname>Lowe</surname><given-names>JE</given-names></name><name><surname>Rasmussen</surname><given-names>MM</given-names></name><name><surname>Jennings</surname><given-names>RB</given-names></name></person-group><article-title>The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs</article-title><source>Circulation</source><year>1977</year><volume>56</volume><issue>5</issue><fpage>786</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.56.5.786</pub-id><pub-id pub-id-type="pmid">912839</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solares</surname><given-names>J</given-names></name><name><surname>Garcia-Dorado</surname><given-names>D</given-names></name><name><surname>Oliveras</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>MA</given-names></name><name><surname>Ruiz-Meana</surname><given-names>M</given-names></name><name><surname>Barrabes</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Contraction band necrosis at the lateral borders of the area at risk in reperfused infarcts. Observations in a pig model of in situ coronary occlusion</article-title><source>Virchows Archiv : Intl J Pathol</source><year>1995</year><volume>426</volume><issue>4</issue><fpage>393</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/BF00191349</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beek</surname><given-names>AM</given-names></name><name><surname>Kuhl</surname><given-names>HP</given-names></name><name><surname>Bondarenko</surname><given-names>O</given-names></name><name><surname>Twisk</surname><given-names>JW</given-names></name><name><surname>Hofman</surname><given-names>MB</given-names></name><name><surname>van Dockum</surname><given-names>WG</given-names></name><etal/></person-group><article-title>Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>42</volume><issue>5</issue><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(03)00835-0</pub-id><pub-id pub-id-type="pmid">12957439</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dall'Armellina</surname><given-names>E</given-names></name><name><surname>Karia</surname><given-names>N</given-names></name><name><surname>Lindsay</surname><given-names>AC</given-names></name><name><surname>Karamitsos</surname><given-names>TD</given-names></name><name><surname>Ferreira</surname><given-names>V</given-names></name><name><surname>Robson</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index</article-title><source>Circ Cardiovasc Imaging</source><year>2011</year><volume>4</volume><issue>3</issue><fpage>228</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.111.963421</pub-id><pub-id pub-id-type="pmid">21447711</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>T</given-names></name><name><surname>Nekolla</surname><given-names>SG</given-names></name><name><surname>Hornke</surname><given-names>M</given-names></name><name><surname>Bulow</surname><given-names>HP</given-names></name><name><surname>Dirschinger</surname><given-names>J</given-names></name><name><surname>Schomig</surname><given-names>A</given-names></name><etal/></person-group><article-title>Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>45</volume><issue>4</issue><fpage>544</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2004.10.058</pub-id><pub-id pub-id-type="pmid">15708702</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingkanisorn</surname><given-names>WP</given-names></name><name><surname>Rhoads</surname><given-names>KL</given-names></name><name><surname>Aletras</surname><given-names>AH</given-names></name><name><surname>Kellman</surname><given-names>P</given-names></name><name><surname>Arai</surname><given-names>AE</given-names></name></person-group><article-title>Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>43</volume><issue>12</issue><fpage>2253</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2004.02.046</pub-id><pub-id pub-id-type="pmid">15193689</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amado</surname><given-names>LC</given-names></name><name><surname>Gerber</surname><given-names>BL</given-names></name><name><surname>Gupta</surname><given-names>SN</given-names></name><name><surname>Rettmann</surname><given-names>DW</given-names></name><name><surname>Szarf</surname><given-names>G</given-names></name><name><surname>Schock</surname><given-names>R</given-names></name><etal/></person-group><article-title>Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><issue>12</issue><fpage>2383</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2004.09.020</pub-id><pub-id pub-id-type="pmid">15607402</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>LY</given-names></name><name><surname>Natanzon</surname><given-names>A</given-names></name><name><surname>Kellman</surname><given-names>P</given-names></name><name><surname>Hirsch</surname><given-names>GA</given-names></name><name><surname>Aletras</surname><given-names>AH</given-names></name><name><surname>Arai</surname><given-names>AE</given-names></name></person-group><article-title>Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm.</article-title><source>J Magn Reson Imaging: JMRI</source><year>2006</year><volume>23</volume><issue>3</issue><fpage>298</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1002/jmri.20496</pub-id><pub-id pub-id-type="pmid">16450367</pub-id></element-citation></ref></ref-list></back></article>